Description
This peptide is a derivative of the N-terminal end of cecropin B and the C-terminal end of thanatin that exhibits antimicrobial peptide (AMP) activity.
This peptide is a derivative of the N-terminal end of cecropin B and the C-terminal end of thanatin that exhibits antimicrobial peptide (AMP) activity.
| Purity | ≥95% |
|---|---|
| Formula | C138H230N46O34S4 |
| Formula Wt. | 3205.89 |
| Solubility | Soluble in water. |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet |
Hongbiao W, Baolong N, Mengkui X, et al. Biological activities of cecropin B-thanatin hybrid peptides. J Pept Res. 2005 Dec;66(6):382-6. PMID: 16316454.
Neuroactive mycotoxin produced by Penicillum an...
SIRT1/2 inhibitor.
Nucleoside (guanosine) analog; RT, guanylyl cyc...
ROCK1/2 inhibitor, potential RSK and p70S6K inh...
Long-chain 3-ketoacyl-CoA thiolase inhibitor, p...
Akt inhibitor.
α7 and β4 nAChR agonist, α4β2 and α6β2 nA...
Polyether Ca2+ ionophore.
Endogenous peptide hormone, involved in enteric...
Endogenous peptide involved in vascular contrac...
Amino amide; voltage-gated Na+, BK/SK, Kv1, Kv3...
Endogenous cardiomodulatory peptide; NPR-A agon...
Abl, PDGFR, EphR, Src, k-Kit, FYN, LCK, HCK inh...
May be useful against COVID-19
Macrolide antibiotic
Echinocandin
Thiazolidinedione; PPARγ agonist.
HDAC inhibitor.
Ansamycin; bacterial DNA-dependent RNA polymera...
TrkB agonist.